{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:31:03Z","timestamp":1786987863226,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002613","name":"Ulsan National Institute of Science and Technology","doi-asserted-by":"publisher","award":["1.190039.01"],"award-info":[{"award-number":["1.190039.01"]}],"id":[{"id":"10.13039\/501100002613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002613","name":"Ulsan National Institute of Science and Technology","doi-asserted-by":"publisher","award":["NRF-2014H1A2A1019656"],"award-info":[{"award-number":["NRF-2014H1A2A1019656"]}],"id":[{"id":"10.13039\/501100002613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- 2018R1A5A1024340"],"award-info":[{"award-number":["NRF- 2018R1A5A1024340"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1E1A1A074673"],"award-info":[{"award-number":["2017R1E1A1A074673"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C1089260"],"award-info":[{"award-number":["2019R1A2C1089260"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ebiom.2020.102926","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:30:13Z","timestamp":1596069013000},"page":"102926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance"],"prefix":"10.1016","volume":"58","author":[{"given":"Jun Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hee","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Je","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Youn","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whaseon","family":"Lee-Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Ah","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyu Won","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neung Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3244-2025","authenticated-orcid":false,"given":"Hyug Moo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102926_bib0001","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1470-2045(12)70271-1","article-title":"Biomarkers for early diagnosis of hepatocellular carcinoma","volume":"13","author":"Forner","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0002","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102926_bib0003","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/SLA.0b013e3182111195","article-title":"Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience","volume":"253","author":"Fan","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ebiom.2020.102926_bib0004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","article-title":"Cancer stem cells: basic concepts and therapeutic implications","volume":"11","author":"Nassar","year":"2016","journal-title":"Annu Rev Pathol: Mech Dis"},{"key":"10.1016\/j.ebiom.2020.102926_bib0005","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMra1804280","article-title":"Clinical and therapeutic implications of cancer stem cells","volume":"380","author":"Clarke","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102926_bib0006","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","article-title":"Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance","volume":"54","author":"Easwaran","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.ebiom.2020.102926_bib0007","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102926_bib0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fonc.2019.00309","article-title":"The prognostic and clinical value of CD44 in colorectal cancer: a meta-analysis","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0009","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40169-018-0198-1","article-title":"The role of CD133 in cancer: a concise review","volume":"7","author":"Glumac","year":"2018","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.ebiom.2020.102926_bib0010","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","article-title":"EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features","volume":"136","author":"Yamashita","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2020.102926_bib0011","doi-asserted-by":"crossref","first-page":"e81050","DOI":"10.1371\/journal.pone.0081050","article-title":"Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.102926_bib0012","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4254\/wjh.v2.i3.114","article-title":"Hepatic cancer stem cells and drug resistance: relevance in targeted therapies for hepatocellular carcinoma","volume":"2","author":"Sukowati","year":"2010","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0013","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/hep.24559","article-title":"Human hepatocellular carcinomas with \u201cStemness\u201d-related marker expression: keratin 19 expression and a poor prognosis","volume":"54","author":"Kim","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2020.102926_bib0014","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/cells5020016","article-title":"The NF-\u03baB pathway and cancer stem cells","volume":"5","author":"Rinkenbaugh","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.ebiom.2020.102926_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: STAT3 and NF-\u03baB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ebiom.2020.102926_bib0016","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.1121513","article-title":"Molecular linkage between the kinase ATM and NF-\u03baB signaling in response to genotoxic stimuli","volume":"311","author":"Wu","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102926_bib0017","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1073\/pnas.96.5.2538","article-title":"Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity","volume":"96","author":"Miyakawa","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ebiom.2020.102926_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-020-0261-1","article-title":"The evolving role of TonEBP as an immunometabolic stress protein","author":"Choi","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0019","doi-asserted-by":"crossref","first-page":"24921","DOI":"10.1038\/srep24921","article-title":"LPS-induced NF\u03baB enhanceosome requires TonEBP\/NFAT5 without DNA binding","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2020.102926_bib0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20111569","article-title":"Gene expression induced by toll-like receptors in macrophages requires the transcription factor NFAT5","volume":"209","author":"Buxad\u00e9","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2020.102926_bib0021","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1681\/ASN.2017070718","article-title":"Tonicity-responsive enhancer-binding protein mediates hyperglycemia-induced inflammation and vascular and renal injury","volume":"29","author":"Choi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0022","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1172\/JCI87880","article-title":"Transcription factor NFAT5 promotes macrophage survival in rheumatoid arthritis","volume":"127","author":"Choi","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ebiom.2020.102926_bib0023","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fphys.2012.00313","article-title":"NFAT5 expression in bone marrow-derived cells enhances atherosclerosis and drives macrophage migration","volume":"3","author":"Halterman","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0024","doi-asserted-by":"crossref","first-page":"10937","DOI":"10.1038\/srep10937","article-title":"TonEBP suppresses adipogenesis and insulin sensitivity by blocking epigenetic transition of PPAR\u03b32","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2020.102926_bib0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.isci.2019.07.021","article-title":"TonEBP Regulates PCNA polyubiquitination in response to DNA damage through interaction with SHPRH and USP1","volume":"19","author":"Kang","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.ebiom.2020.102926_bib0026","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gutjnl-2017-315348","article-title":"Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis","volume":"68","author":"Lee","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2020.102926_bib0027","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2011.09.012","article-title":"Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands","volume":"20","author":"O'Hagan Heather","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2020.102926_bib0028","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.stem.2015.03.003","article-title":"The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling","volume":"16","author":"Wang","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ebiom.2020.102926_bib0029","first-page":"2039","article-title":"Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC","volume":"15","author":"Qiu","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ebiom.2020.102926_bib0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18(5)","author":"Taniguchi","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0031","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1158\/0008-5472.CAN-10-0732","article-title":"The canonical NF-\u03baB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion","volume":"70","author":"Liu","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2020.102926_bib0032","first-page":"8","article-title":"Inhibition of NF-\u03baB signaling reduces the stemness characteristics of lung cancer stem cells","author":"Zakaria","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0033","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/cr.2017.41","article-title":"Self-inflicted DNA double-strand breaks sustain tumorigenicity and stemness of cancer cells","volume":"27","author":"Liu","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.ebiom.2020.102926_bib0034","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non\u2013small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102926_bib0036","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/annonc\/mdl435","article-title":"Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy","volume":"18","author":"Bellmunt","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ebiom.2020.102926_bib0037","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.ebiom.2020.102926_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183662","article-title":"Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance","volume":"12","author":"Edwardson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.102926_bib0039","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.dnarep.2010.03.010","article-title":"Downregulation of XPF\u2013ERCC1 enhances cisplatin efficacy in cancer cells","volume":"9","author":"Arora","year":"2010","journal-title":"DNA Repair"},{"key":"10.1016\/j.ebiom.2020.102926_bib0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/0008-5472.CAN-12-1733","article-title":"Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating notch signaling","volume":"73","author":"Liu","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ebiom.2020.102926_bib0041","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2010.09.043","article-title":"DNA damage-mediated induction of a chemoresistant niche","volume":"143","author":"Gilbert","year":"2010","journal-title":"Cell"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420303017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420303017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:33:35Z","timestamp":1778873615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420303017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":41,"alternative-id":["S2352396420303017"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102926","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102926"}}